Sanofi’s Large Molecules Research Data Platform
Automating Gene Therapy Long-Read Based QC Assays
Safety of Human Cell Products: The Value of NGS
MS-Based Profiling, Fingerprinting, & Speciation of Polymeric Excipients
Automated & Interactional Ion Channel Data Analysis
A Lean and Smart Approach for Setting Up an Antibody Development Platform
Robust NGS Pipelines for Virus Detection
MS-based Analytics for the Investigation of In Vivo Biotransformation of Biotherapeutics
Overcoming the Challenges of Disulfide Bond Characterization
Japan: What Digital Platforms Can Bring to Biomarker Researchers
AbbVie Streamlines Multi-Specifics Biologics Discovery and Engineering
Fully Automated NGS Assays in a GMP Environment
Considerations for a GMP-Compliant NGS Method
Nanopore Sequencing for AAV Vectors & DNA Impurities
Selector Playbooks: Automation of NGS Workflows
NGS Implementation for Adventitious Virus Detection
What’s New in Genedata Screener 21
Genedata Selector Open Forum 8: Introduction by Astellas
GMP-Compliant Viral Risk Assessment of Live Vaccines
NGS as a Multi-Attribute Method for Cell Therapy Production QC
E2E Data Platform to Digitalize & Automate Single-Domain Antibody (sdAbs) R&D
Digitalizing Across mAbs, Bispecifics, ADCs
Japan: JBA "NGS for CQA Assessment of Biological Products"
Process Changes Impacting AAV CQAs Assessed with NGS
NGS as MAM to Support AAV Gene Therapy Production
Automating Peptide Mapping Data Analysis Workflows
Now is the Time for MS Screening Labs to Scale Up Projects
ScRNA-seq for Cell Line Heterogeneity Assessment
Comprehensive Biosafety for Viral Vector Vaccines
What’s New in Genedata Screener 20
Advancing a Prognostic Biomarker Panel for Pediatric Crohn’s Disease
Unlocking Translational Insights from Tempus Real-World Data
Automation of Biosafety and Critical Quality Attribute Assessment
Evaluating Random Transgene Integration Using NGS
MS-Based Characterization of N- and O-Linked Glycosylation Sites
Automating Image Analysis with Deep Learning
Accelerated mAb Manufacturing 3 Months to GMP
Japan: Benefits of Expressionist Workflows in MS Data Analysis
What's New in Screener 19 and Imagence 5
Newly Discovered miRNA Impacts CHO Monoclonal Antibodies
